Brought to you by 
SB Clin. acquires rights to genetic tests from Progenitor
13 Jul 1999
Executive Summary
SB Clin. Labs has acquired exclusive rights to develop and perform genetic tests in the US, parts of Central and S. America, Europe and the Pacific Rim for hereditary hemochromatosis, patents of which are covered under Progenitor's applications.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SB Clin. acquires rights to genetic tests from Progenitor
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice